Project description
Bioprinting: the future of transplantation
Tissue bioprinting is a novel technology that uses biomaterials to produce constructs for potential clinical use. This approach is expected in the future to address the shortage of donor tissues and organs needed to treat many chronic diseases. INKspired is an EU-funded initiative that will advance bioprinting by developing bioinks based on the extracellular matrix that also combine the capacity to modulate the immune response. This will help recreate the native complexity of tissues more accurately and improve the mechanical and biological properties of printed constructs. Importantly, it will bring bioprinting one step closer to generating implantable living tissues.
Objective
Tissue and organ shortage is the limiting factor in treating many patients with chronic organ failure and has led to over 18 patients deaths every day just in Europe. Recreating the 3D complexity of tissues and organs is moving step-by-step from sci-fi to reality thanks to the tremendous progress in 3D printing techniques. Native tissues and organs are composed of different cells, proteins, and signaling molecules that are arranged in a hierarchical complex microenvironment, called extracellular matrix (ECM). Bioprinting has emerged as a novel fabrication technique that assembles cells-laden biomaterials in a spatially controlled manner, promising customized 3D tissue-engineered constructs for potential clinical use. One of the main challenges to clinical success is to avoid immune system rejection. The overall aim of the INKspired project is to generate novel ECM-inspired bioinks, which could further recapitulate the dynamicity and complex structure of native tissue and even modulate the immune response. By double network strategy, I will combine two dynamic hydrogel networks to control the overall mechanical and biological properties of printed constructs. The outcomes of INKspired aim to contribute to tissue bioprinting and hence the global chronic lack of tissues.
My unique research background, which includes tissue engineering, material science and engineering, will allow me to carry out this multidisciplinary project. I will collaborate with the supervisors, who have a vast experience in biofabrication and biomaterials, and work at the international and interdisciplinary setting (MERLN, Maastricht University). Marie Curie fellowship will enhance the potential of my future career perspectives by providing an interdisciplinary and translational education program, empowering me to take leading positions in the field of tissue engineering worldwide.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteins
- medical and health sciencesmedical biotechnologytissue engineering
- medical and health sciencesbasic medicineimmunology
- engineering and technologymechanical engineeringmanufacturing engineeringadditive manufacturing
- engineering and technologyindustrial biotechnologybiomaterials
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Programme(s)
Funding Scheme
MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)Coordinator
6200 MD Maastricht
Netherlands